Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $2.26 billion. The enterprise value is $2.30 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 49.53 million shares outstanding. The number of shares has increased by 11.15% in one year.
| Current Share Class | 49.53M |
| Shares Outstanding | 49.53M |
| Shares Change (YoY) | +11.15% |
| Shares Change (QoQ) | +2.88% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 92.89% |
| Float | 39.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.77 |
| Forward PS | n/a |
| PB Ratio | 9.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 1.36.
| Current Ratio | 3.22 |
| Quick Ratio | 2.93 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.33 |
Financial Efficiency
Return on equity (ROE) is -33.06% and return on invested capital (ROIC) is -8.73%.
| Return on Equity (ROE) | -33.06% |
| Return on Assets (ROA) | -7.11% |
| Return on Invested Capital (ROIC) | -8.73% |
| Return on Capital Employed (ROCE) | -13.56% |
| Revenue Per Employee | $1.18M |
| Profits Per Employee | -$240,186 |
| Employee Count | 322 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 3.94 |
Taxes
In the past 12 months, MIRM has paid $1.44 million in taxes.
| Income Tax | 1.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.05% in the last 52 weeks. The beta is 0.96, so MIRM's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +84.05% |
| 50-Day Moving Average | 43.16 |
| 200-Day Moving Average | 43.09 |
| Relative Strength Index (RSI) | 60.21 |
| Average Volume (20 Days) | 431,337 |
Short Selling Information
The latest short interest is 6.23 million, so 12.57% of the outstanding shares have been sold short.
| Short Interest | 6.23M |
| Short Previous Month | 6.28M |
| Short % of Shares Out | 12.57% |
| Short % of Float | 15.73% |
| Short Ratio (days to cover) | 14.10 |
Income Statement
In the last 12 months, MIRM had revenue of $379.25 million and -$77.34 million in losses. Loss per share was -$1.61.
| Revenue | 379.25M |
| Gross Profit | 292.42M |
| Operating Income | -76.32M |
| Pretax Income | -107.43M |
| Net Income | -77.34M |
| EBITDA | -52.30M |
| EBIT | -76.32M |
| Loss Per Share | -$1.61 |
Full Income StatementBalance Sheet
The company has $277.67 million in cash and $317.16 million in debt, giving a net cash position of -$39.48 million or -$0.80 per share.
| Cash & Cash Equivalents | 277.67M |
| Total Debt | 317.16M |
| Net Cash | -39.48M |
| Net Cash Per Share | -$0.80 |
| Equity (Book Value) | 233.26M |
| Book Value Per Share | 4.72 |
| Working Capital | 283.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.85 million and capital expenditures -$1.02 million, giving a free cash flow of -$7.87 million.
| Operating Cash Flow | -6.85M |
| Capital Expenditures | -1.02M |
| Free Cash Flow | -7.87M |
| FCF Per Share | -$0.16 |
Full Cash Flow StatementMargins
Gross margin is 77.10%, with operating and profit margins of -20.12% and -20.39%.
| Gross Margin | 77.10% |
| Operating Margin | -20.12% |
| Pretax Margin | -20.01% |
| Profit Margin | -20.39% |
| EBITDA Margin | -13.79% |
| EBIT Margin | -20.12% |
| FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.15% |
| Shareholder Yield | -11.15% |
| Earnings Yield | -3.43% |
| FCF Yield | -0.35% |
Dividend DetailsAnalyst Forecast
The average price target for MIRM is $60.80, which is 33.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.80 |
| Price Target Difference | 33.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 26.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 3 |